These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11278248)

  • 1. Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty.
    Tagalakis AD; Graham IR; Riddell DR; Dickson JG; Owen JS
    J Biol Chem; 2001 Apr; 276(16):13226-30. PubMed ID: 11278248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of the neuropathogenic human apolipoprotein E4 (APOE4) gene to APOE3 in vitro using synthetic RNA/DNA oligonucleotides (chimeraplasts).
    Tagalakis AD; Dickson JG; Owen JS; Simons JP
    J Mol Neurosci; 2005; 25(1):95-103. PubMed ID: 15781970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to generate atheroprotective apolipoprotein AI phenotypes using synthetic RNA/DNA oligonucleotides (chimeraplasts).
    Manzano A; Mohri Z; Sperber G; Ogris M; Graham I; Dickson G; Owen JS
    J Gene Med; 2003 Sep; 5(9):795-802. PubMed ID: 12950070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chylomicron remnant uptake in the livers of mice expressing human apolipoproteins E3, E2 (Arg158-->Cys), and E3-Leiden.
    Lee SJ; Grosskopf I; Choi SY; Cooper AD
    J Lipid Res; 2004 Dec; 45(12):2199-210. PubMed ID: 15466367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW; van Vlijmen BJ; van der Zee A; van't Hof B; van der Boom H; Kobayashi K; Chan L; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
    Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
    J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E2-Dunedin (228 Arg replaced by Cys): an apolipoprotein E2 variant with normal receptor-binding activity.
    Wardell MR; Rall SC; Brennan SO; Nye ER; George PM; Janus ED; Weisgraber KH
    J Lipid Res; 1990 Mar; 31(3):535-43. PubMed ID: 2341812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW; van Vlijmen BJ; de Winther MP; van 't Hof B; van der Zee A; van der Boom H; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2945-51. PubMed ID: 10591674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
    Van Eck M; Herijgers N; Van Dijk KW; Havekes LM; Hofker MH; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):119-27. PubMed ID: 10634808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression of apolipoprotein E3 and its variant apoE2 and apoE4.
    Zong Y; Liu Z; Bi H; Yao Y; Guo J; Qu S
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(1):1-3, 16. PubMed ID: 16710994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2.
    Huang Y; Rall SC; Mahley RW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2817-24. PubMed ID: 9409260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice.
    Athanasopoulos T; Owen JS; Hassall D; Dunckley MG; Drew J; Goodman J; Tagalakis AD; Riddell DR; Dickson G
    Hum Mol Genet; 2000 Oct; 9(17):2545-51. PubMed ID: 11030760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral phenotype and BDNF differences related to apoE isoforms and sex in young transgenic mice.
    Reverte I; Klein AB; Ratner C; Domingo JL; Colomina MT
    Exp Neurol; 2012 Sep; 237(1):116-25. PubMed ID: 22735491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of APOE gene polymorphism with subclasses of serum high density lipoprotein in hyperlipidemia].
    Long SY; Zhang XM; Fu MD; Xu YH; Liu BW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):615-8. PubMed ID: 15583995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on apoE gene polymorphism and subclasses of serum high density lipoprotein in type IV hyperlipidemia].
    Tian Y; Long SY; Xu YH; Fu MD; Zhang XM; Liu BW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):96-8. PubMed ID: 15696494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of human apolipoprotein E2, E3 and E4 in solution. 2. Multidomain organization correlates with the stability of apoE structure.
    Clément-Collin V; Barbier A; Dergunov AD; Visvikis A; Siest G; Desmadril M; Takahashi M; Aggerbeck LP
    Biophys Chem; 2006 Jan; 119(2):170-85. PubMed ID: 16125836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.